Ronil Patel
Equibles does not estimate personal net worth.
Get an email with a short summary when Opus Genetics, Inc. publishes a filing, an earnings call transcript or a press release.
Get IRD alertsAbout Ronil Patel
Opus Genetics, Inc. reported in an 8-K filed December 6, 2023 that Ronil Patel was appointed Chief Business Officer, effective December 1, 2023. Opus Genetics, Inc. is classified in the Biotechnology industry within the Healthcare sector. Other leadership on record at Opus Genetics, Inc. includes Dr. George Magrath (CEO and Board Member), George Magrath (CEO and Board Member), George Magrath, M.D., M.B.A., M.S. (CEO and Board Member) and 7 others.
“On December 1, 2023, the Board of Directors (the “Board”) of Ocuphire Pharma, Inc. (the “Company”) promoted Ronil Patel, age 40, as the Company’s Chief Business Officer, effective as of December 1, 2023.”
Affiliation history
-
Opus Genetics, Inc. (IRD)
SEC 8-K
Current2023-12-01–present
Company network
Leadership on record at Opus Genetics, Inc.
- Dr. George Magrath CEO, Board Member
- George Magrath CEO, Board Member
- George Magrath, M.D., M.B.A., M.S. CEO, Board Member
- Richard Rodgers CEO, Board Member
- Cam Gallagher Chairman, Board Member
- Nirav Jhaveri CFO
- Rob Gagnon CFO
- Robert Gagnon CFO, Chief Accounting Officer
- Joseph K. Schachle COO
- Joseph Schachle COO